Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1157431
                    [Title] => Simvastatin label now discourages higher dose
                    [Summary] => 
A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

                    [DatePublished] => 2013-09-01 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 695026
                    [Title] => Unapproved narcotic gets reprieve from FDA
                    [Summary] => 
The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the market.
                    [DatePublished] => 2011-06-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 557286
                    [Title] => FDA announces new warning on anti-blood clotting drug Plavix
                    [Summary] => 
WASHINGTON (Xinhua) -- The U.S. Food and Drug Administration on Friday added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form. 
                    [DatePublished] => 2010-03-13 12:49:42
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 540958
                    [Title] => Johnson & Johnson issues massive recall of Tylenol
                    [Summary] => 
NEW YORK (AP) — Johnson & Johnson issued a massive recall of over-the-counter drugs including Tylenol, Motrin and St. Joseph's aspirin because of a moldy smell that has made people sick.
                    [DatePublished] => 2010-01-16 15:07:57
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

DRUG EVALUATION AND RESEARCH

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1157431
                    [Title] => Simvastatin label now discourages higher dose
                    [Summary] => 
A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

                    [DatePublished] => 2013-09-01 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 695026
                    [Title] => Unapproved narcotic gets reprieve from FDA
                    [Summary] => 
The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the market.
                    [DatePublished] => 2011-06-12 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 557286
                    [Title] => FDA announces new warning on anti-blood clotting drug Plavix
                    [Summary] => 
WASHINGTON (Xinhua) -- The U.S. Food and Drug Administration on Friday added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can be less effective in people who cannot metabolize the drug to convert it to its active form. 
                    [DatePublished] => 2010-03-13 12:49:42
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 540958
                    [Title] => Johnson & Johnson issues massive recall of Tylenol
                    [Summary] => 
NEW YORK (AP) — Johnson & Johnson issued a massive recall of over-the-counter drugs including Tylenol, Motrin and St. Joseph's aspirin because of a moldy smell that has made people sick.
                    [DatePublished] => 2010-01-16 15:07:57
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest

Simvastatin label now discourages higher dose

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | September 1, 2013 - 12:00am

A recommendation against prescribing the highest available dose of simvastatin is among the changes in the labeling information for the drug, the Food and Drug Administration announced.

Opinion

Unapproved narcotic gets reprieve from FDA

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 12, 2011 - 12:00am

The Food and Drug Administration has backed off from a warning letter it sent to several manufacturers and decided to allow an unapproved version of high-concentrate morphine sulfate oral solution to remain on the...

Opinion

FDA announces new warning on anti-blood clotting drug Plavix

March 13, 2010 - 12:49pm

WASHINGTON (Xinhua) -- The U.S. Food and Drug Administration on Friday added a boxed warning to the anti-blood clotting drug Plavix (clopidogrel), alerting patients and health care professionals that the drug can...

Johnson & Johnson issues massive recall of Tylenol

January 16, 2010 - 3:07pm

NEW YORK (AP) — Johnson & Johnson issued a massive recall of over-the-counter drugs including Tylenol, Motrin and St. Joseph's aspirin because of a moldy smell that has made people sick.